Targeting the invisible: precision fiducial marker placement in poorly visible liver tumors prior to percutaneous ablation using real-time image fusion guidance
The present work suggests that pre-PTA placement of a fiducial marker in poorly visible tumors using real-time US-CT/MRI fusion imaging is accurate, potentially enhancing the effectiveness of subsequent PTA.
Authors
- Pascal Rousset (ORCID: https://orcid.org/0000-0001-6956-2800)
- Antoine Muller (ORCID: https://orcid.org/0000-0003-2606-1429)
- Guillaume Passot (ORCID: https://orcid.org/0000-0003-3094-3491)
- Georgia Tsoumakidou (ORCID: https://orcid.org/0000-0002-3659-7633)
- Nicolas Villard
- Laurent Milot (ORCID: https://orcid.org/0000-0001-5175-3713)
- Jérôme Dumortier (ORCID: https://orcid.org/0000-0002-7824-5396)
- P J Valette
- Frédérique Gay
Institutions
- Hospices Civils de Lyon (FR)
- University of Lausanne (CH)
Publication Details
- Journal
- Frontiers in Radiology
- Published
- 2025-11-20
- DOI
- https://doi.org/10.3389/fradi.2025.1659739
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00